Table 2.

Fasting glucose, insulin, and HOMA-IR profiles in different study groups.

Variables	Control group	T2DM group	AD-MSCs group	AD-MSCs pretreated with OXA group
Fasting glucose (mmol/l)	6.1 ± 0.16	17.5 ± 3.1a	9.6 ± 1.2abc	7.1 ± 0.64b
Insulin (mU/l)	8.1 ± 0.10	18.4 ± 1.1a	11.8 ± 1.2abc	9.7 ± 0.46ab
HOMA-IR	2.2 ± 0.11	14.3 ± 2.7a	5.1 ± 1.2abc	3.1 ± 0.44b

The results are reported as mean ± SD; n = 7 each. p^a < 0.001 as compared to the control group, p^b < 0.001 as compared to the T2DM group, and p^c < 0.001 as compared to AD-MSCs pretreated with the OXA group. T2DM group/T2DM: type 2 diabetes; AD-MSCs: adipose-derived mesenchymal stem cells; OXA: orexin A; HOMA-IR: homeostatic model assessment of insulin resistance index. The significance level was set at p < 0.05.